Welcome To Off The Radar
HPV Vaccine Adverse Events Reported to VAERS as of October 14, 2012

November 18, 2012  By

HPV4 Gardasil & HPV 2 Cervarix – Adverse Reactions and Deaths as reported to the Vaccine Adverse Event Reporting System

Janny Stokvis, HPV Vaccine VAERS  researcher and analyst has compiled that latest adverse events from the HPV vaccines, Gardasil and Cervarix as reported to the Vaccine Adverse Event Reporting System. It is estimated only 1 to 10% of the vaccine injured are reporting. Please note the significant number of girls reporting abnormal pap smears, cervical dysplasia and cervical cancer.  Remember most women do not get cervical cancer until their 50?s or even older.  The reports here are for girls ages 9 to 26 – the market the vaccines were approved for.


By Norma Erickson, President - October 23 2012

altFor the first time in history, a biologically plausible mechanism of action has been discovered linking a vaccine to a serious adverse event. Gardasil has left behind its genetic fingerprint in post-mortem central nervous system samples of two girls who took this vaccine.

Two teenage girls from opposite ends of the world – both dead before their time have two additional things in common. They both took Gardasil to try and prevent cervical cancer and fragments of the HPV-16-L1 antigen used in Gardasil have been found in blood vessels within their brains.


From Population Research Institute - 12 October 2012

Can Gardasil cause sterility? A case from Australia reported in the British Medical Journal raises the possibility that the vaccine, which has been given to millions of young girls around the world, may in some cases cause “ovarian failure.”

Teenage Girl Becomes Infertile after Gardasil Vaccination

by Steven Mosher and Elizabeth Crnkovich

Gardasil has been controversial from the beginning. While other vaccines protect against diseases spread by casual contact, Gardasil was developed to protect against a sexually transmitted disease called Human Papilloma Virus or HPV. Merck & Co., the manufacturer, has been very effective at lobbying governments around the world to make the vaccine mandatory for school attendance. Despite the frequent objections of doctors and parents, it has been administered to tens of millions of 11- and 12-year-old young girls around the world.

Now comes the case of a 16-year-old Australian girl who suffered "premature ovarian failure" after receiving Gardasil. Her ovaries have shut down, her eggs have been destroyed, and she will never be able to have children.

By Gail Johnson, November 1, 2012
A human papillomavirus (HPV) vaccine may trigger fatal autoimmune or neurological events in some cases, two UBC researchers say. Their findings come as public-health authorities, who maintain that the shots are safe, are urging young women to get vaccinated to prevent cervical cancer.

Neuroscientist Chris Shaw and Lucija Tomljenovic, who has a PhD in biochemistry and is a senior postdoctoral fellow in UBC’s faculty of medicine, say that research on the HPV vaccine Gardasil (which is given in three shots over a six-month period) raises serious concerns and that the risk of adverse reactions is largely downplayed. In an interview at their lab, they maintain that the vaccine needs more scrutiny before health agencies promote it in public campaigns.

“For reasons that are not understood, some people are having terrible reactions to this vaccine,” Shaw says. “Some people are more susceptible. Most people who get these vaccines are fine.…But some people may get sick from these vaccines, so claiming that there are no adverse reactions aside from a sore arm is not strictly true.”


By Norma Erickson, President - 8 August 2012

altTestimony provided by Dr. Sin Hang Lee via an international video link before Coroner Ian Smith in Wellington NZ revealed the discovery of Gardasil® HPV DNA fragments in post-mortem samples. This inquest was conducted to examine the facts surrounding the unexplained death of Jasmine Renata six months after Gardasil® vaccination.

Dr. Lee, a pathologist on the medical staff at Connecticut’s Milford Hospital, testified:

“The finding of these foreign DNA fragments in the post-mortem samples six months after vaccination indicates that some of the residual DNA fragments from the viral gene or plasmid injected with Gardasil® have been protected from degradation in the form of DNA-aluminum complexes in the macrophages; or via integration into the human genome.

Undegraded viral and plasmid DNA fragments are known to activate macrophages, causing them to release tumor necrosis factor, a myocardial depressant which can induce lethal shock in animals and humans.”

Dr. Lee stated, “The naked DNA in the vaccine was probably stabilized through a chemical binding between the mineral aluminum and the phosphate backbone of the double-stranded DNA.”

Dr. Lee did not claim the HPV-16 L1 gene DNA he discovered in the post-mortem blood and spleen samples was the cause of the sudden and unexplained death of the New Zealand teenager in her sleep. He did note that since the full autopsy analysis had ruled out all known causes of death, his discovery presented a plausible mechanism of action that needed further investigation in all cases of unexplained deaths following Gardasil® vaccinations.

Dr. Lee had previously tested a total of 16 Gardasil® samples from around the world under contract with the non-profit organization SaneVax Inc. Five of those Gardasil® samples were distributed in New Zealand, each with a different lot number. Dr Lee found HPV-16 L1 gene DNA fragments admixed with HPV-18 and/or HPV 11 L1 gene DNA in all samples.

These HPV DNA fragments were firmly bound to the amorphous aluminum hydroxyphosphate sulfate (AAHS) particles used as an adjuvant in the vaccine formulation.

Fragments of HPV rDNA firmly attached to the aluminum adjuvant have been found in 100% of Gardasil® samples tested. Various regulatory agencies agree these particles are in the vaccine, but claim they pose no health risk. These same HPV rDNA particles have been found in blood and spleen samples of a girl who died shortly after vaccination with Gardasil.

What does this mean for medical consumers? It leaves them with numerous questions that demand answers:

  • Do all lots of Gardasil® contain HPV DNA residue?
  • Is the HPV rDNA found in blood and spleen samples still firmly attached to the aluminum adjuvant?
  • Do post-mortem samples from others who have died without explanation after Gardasil® also contain HPV DNA?
  • Do those who have experienced severe adverse reactions after Gardasil® have HPV DNA in their blood? Or, at the site of injection?
  • Are these particles bound to the host macrophages (white blood cells that normally destroy foreign particles and infectious microorganisms) rather than being destroyed as wild HPV would have been?
  • Could injected HPV rDNA activate the production of TNF (tumor necrosis factor) or other cytokines associated with autoimmune disorders?
  • Does this HPV rDNA have the capability of integrating with the host DNA and causing mutations that may lead to cancer?

According to Dr. Lee:

“There are only two known ways these HPV DNA fragments would remain in post-mortem tissue. Either the fragments are attached to the aluminum adjuvant and unable to be degraded by the DNA nucleases, or the fragments were integrated into the human genome. Either of these options may have harmful and potentially lethal consequences, and need further investigation.”

Medical consumers worldwide have every right to demand these questions be answered. Until answers are provided the human right to informed consent is being violated.

It is time for government health authorities around the world to provide autopsy samples from all deaths subsequent to Gardasil® to independent laboratories with suitable technology, in order to provide the answers to these questions for medical consumers. Anything less is a betrayal of the public trust.

Dr. Lee is known for using the nested PCR/DNA sequencing technology for reliable detection and genotyping of HPV in clinical specimens. He is the author of the chapter, “Guidelines for the Use of Molecular

 Tests for the Detection and Genotyping of Human Papillomavirus from Clinical Specimens” in a Methods in Molecular Biology volume published by Humana Press in July 2012.


Page 3 of 15

© Copyright Off The Radar | Supplied by SPF Websites